Literature DB >> 17120972

The feasibility of a school-based VI polysaccharide vaccine mass immunization campaign in Hue City, central Vietnam: streamlining a typhoid fever preventive strategy.

Vu Dinh Thiem1, M Carolina Danovaro-Holliday, Do Gia Canh, Nguyen Dinh Son, Nyugen Thai Hoa, Dang Thi Dieu Thuy, R Leon Ochiai, Nguyen Thi Lan, Tran Quang Hop, Mohammad Ali, Jin Kyung Park, Remon Abu-Elyazeed, Kris Holliday, Bernard Ivanoff, Dang Duc Anh, Tikki Pang, Allan Donner, Claudia M Galindo, Dang Duc Trach, John D Clemens, Camilo J Acosta.   

Abstract

We report the coverage, safety, and logistics of a school-based typhoid fever immunization campaign that took place in Hue City, central Vietnam; a typhoid fever endemic area. A cluster-randomized evaluation-blinded controlled trial was designed where 68 schools (cluster) were randomly allocated the single dose Vi polysaccharide vaccine (Typherix) or the active control hepatitis A vaccine (Havrix). A safety surveillance system was implemented. A total of 32,267 children were immunized with a coverage of 57.5%. Strong predictors for vaccination were attending primary schools, peri-urban location of the school, and low family income. Human resources were mainly schoolteachers and the campaign was completed in about 1 month. Most adverse events reported were mild. Safe injection and safe sharp-waste disposal practices were followed. A typhoid fever school-based immunization campaign was safe and logistically possible. Coverage was moderate and can be interpreted as the minimum that could have been achievable because individual written informed consent procedures were sought for the first time in Hue City and the trial nature of the campaign. The lessons learned, together with cost-effectiveness results to be obtained by the end of follow-up period, will hopefully accelerate the introduction of Vi typhoid fever vaccine in Vietnam.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17120972

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  4 in total

1.  Economic evaluation of typhoid vaccination in a prolonged typhoid outbreak setting: the case of Kasese district in Uganda.

Authors:  Cristina Carias; Maroya Spalding Walters; Edward Wefula; Kashmira A Date; David L Swerdlow; Maya Vijayaraghavan; Eric Mintz
Journal:  Vaccine       Date:  2015-02-21       Impact factor: 3.641

Review 2.  Vaccines for preventing typhoid fever.

Authors:  Rachael Milligan; Mical Paul; Marty Richardson; Ami Neuberger
Journal:  Cochrane Database Syst Rev       Date:  2018-05-31

3.  25 years after Vi typhoid vaccine efficacy study, typhoid affects significant number of population in Nepal.

Authors:  Deepak Bajracharya; M Imran Khan; Alfred Pach; Parisha Shrestha; Nilesh Joshi; Shyam R Upreti; Thomas Wierzba; Mahesh Puri; Sushant Sahastrabuddhe; R Leon Ochiai
Journal:  PLoS One       Date:  2014-01-06       Impact factor: 3.240

4.  Cost of illness due to typhoid Fever in pemba, zanzibar, East Africa.

Authors:  Arthorn Riewpaiboon; Moritz Piatti; Benedikt Ley; Jacqueline Deen; Kamala Thriemer; Lorenz von Seidlein; Mohammad Salehjiddawi; Clara Jana-Lui Busch; Wolfgang H Schmied; Said Mohammed Ali
Journal:  J Health Popul Nutr       Date:  2014-09       Impact factor: 2.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.